ClinicalTrials.gov
public full text
Public Domain
The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension
Exploring the safety, tolerability, and pharmacokinetic (PK) characteristics of oral TPN171H tablets in patients with Pulmonary Arterial Hypertension under continuous multiple administration conditions, providing a basis for determining the administration plan and recommended dosage in phase II clinical study.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)#861106
- A Study of TTYP01 in Healthy Adult Subjects#834786
- A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects#1032691
- Guidelines for Drug Therapy of Hypertension: Closing the Loop#125998
- A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension#383648
Record · ID 903310
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive